We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.31%
This Fund
S&P 500
This Quarter Est. Return
+3.85%
1 Year Est. Return
+106.31%
3 Year Est. Return
+266.76%
5 Year Est. Return
+310.53%
10 Year Est. Return
+1,580.35%
AUM
$4.25B
AUM Growth
+$636M
Cap. Flow
+$222M
Cap. Flow %
5.22%
Top 10 Hldgs %
17.16%
Holding
2,498
New
632
Increased
436
Reduced
368
Closed
712

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$119M
2
PFE icon
Pfizer
PFE
+$60.7M
3
CRM icon
Salesforce
CRM
+$48.4M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$20.6M
5
TSLA icon
Tesla
TSLA
+$20.5M

Top Sells

Rank Stock Value
1
DWACU
Digital World Acquisition Corp. Units
DWACU
+$24.6M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$12.6M
3
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$10.1M
4
HLIT icon
Harmonic Inc
HLIT
+$10.1M
5
FTI icon
TechnipFMC
FTI
+$9.92M

Sector Composition

Rank Sector Weight
1 Financials 10.77%
2 Technology 9.75%
3 Healthcare 8.93%
4 Consumer Discretionary 7.52%
5 Real Estate 3.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMGN icon
1801
Amgen
AMGN
$220B
– –
-2,266
Closed -$482K
AMH icon
1802
American Homes 4 Rent
AMH
$12.4B
– –
-5,849
Closed -$223K
ANAB icon
1803
AnaptysBio
ANAB
$1.63B
– –
-12,260
Closed -$332K
ANF icon
1804
CALL
Abercrombie & Fitch
ANF
$4.86B
– –
-78,900
Closed -$2.97M
ANF icon
1805
PUT
Abercrombie & Fitch
ANF
$4.86B
– –
-12,700
Closed -$478K
AON icon
1806
PUT
Aon
AON
$76.4B
– –
-9,000
Closed -$2.57M
APLS
1807
DELISTED
Apellis Pharmaceuticals
APLS
– –
-34,671
Closed -$1.36M
APLS
1808
PUT
DELISTED
Apellis Pharmaceuticals
APLS
– –
-35,500
Closed -$1.17M
APO icon
1809
Apollo Global Management
APO
$74.8B
– –
-18,938
Closed -$1.17M
APVO icon
1810
Aptevo Therapeutics
APVO
$5.22M
– –
0
– -$237K
ARBK
1811
Argo Blockchain
ARBK
$41.4M
– –
-59
Closed -$203K
ARCO icon
1812
Arcos Dorados Holdings
ARCO
$1.78B
– –
-25,000
Closed -$128K
ARTL icon
1813
Artelo Biosciences
ARTL
$2.62M
– –
-455
Closed -$97K
ASAN icon
1814
PUT
Asana
ASAN
$2.05B
– –
-13,600
Closed -$1.41M
ASML icon
1815
ASML
ASML
$645B
– –
-2,000
Closed -$1.49M
ASND icon
1816
PUT
Ascendis Pharma A/S
ASND
$16B
– –
-32,100
Closed -$5.12M
FRMM
1817
Forum Markets
FRMM
$82.3M
– –
-16
Closed -$333K
ATO icon
1818
Atmos Energy
ATO
$28.7B
– –
-4,505
Closed -$397K
AUPH icon
1819
CALL
Aurinia Pharmaceuticals
AUPH
$1.95B
– –
-19,900
Closed -$440K
AUR icon
1820
Aurora
AUR
$13.1B
– –
-108,190
Closed -$1.07M
AVIR icon
1821
CALL
Atea Pharmaceuticals
AVIR
$380M
– –
-11,300
Closed -$396K
AVPTW
1822
DELISTED
AvePoint Inc Warrant
AVPTW
– –
-30,051
Closed -$255K
AVT icon
1823
Avnet
AVT
$7.97B
– –
-5,510
Closed -$204K
AVTR icon
1824
CALL
Avantor
AVTR
$9.04B
– –
-5,000
Closed -$205K
AXGN icon
1825
Axogen
AXGN
$2.43B
– –
-17,563
Closed -$277K
71 72
73
74 75

Similar funds

MAM
Magellan Asset Management Sydney, Australia $7.71B AUM 11.08% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
WRCM
Whale Rock Capital Management Boston, Massachusetts $7.74B AUM 180.85% 1-Year Est. Return
IMCOOI
Investment Management Corp of Ontario (IMCO) Toronto, Canada $7.76B AUM 99.29% 1-Year Est. Return
CCM
Carronade Capital Management Darien, Connecticut $7.65B AUM 80.26% 1-Year Est. Return
PGFC
Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return
AMH
Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return

Boothbay Fund Management's Q4 2021 Portfolio in Review

As of Q4 2021, Boothbay Fund Management held 2,498 positions worth $4.25B, up 18% from $3.61B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Boothbay Fund Management deployed $222M of net new capital in Q4 2021, opening 632 new positions and adding to 436 existing holdings. Its largest new stake was Pfizer: 1,225,403 shares worth $72.4M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 13% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $12.6M trimmed.

  • Boothbay Fund Management's largest Q4 2021 buy was Pfizer: 1,225,403 shares worth $72.4M.
  • Boothbay Fund Management added most to Amazon in Q4 2021, an estimated $119M increase.
  • Boothbay Fund Management's biggest Q4 2021 reduction was Alphabet (Google) Class C, cutting an estimated $12.6M.
  • Boothbay Fund Management fully exited Digital World Acquisition Corp. Units in Q4 2021, selling an estimated $24.6M.
  • Boothbay Fund Management's ten largest holdings make up 17% of its $4.25B portfolio in Q4 2021.
  • Boothbay Fund Management opened 632 new positions and closed 712 in Q4 2021.
  • Boothbay Fund Management's portfolio value rose 18% quarter-over-quarter to $4.25B.

Based on Boothbay Fund Management's 13F filing for Q4 2021, filed 14 Feb 2022.